» Authors » Dana N LeVine

Dana N LeVine

Explore the profile of Dana N LeVine including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 283
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hall G, Birkbeck R, Brainard B, Camacho F, Davidow E, LeVine D, et al.
J Vet Intern Med . 2024 Sep; 38(5):2495-2506. PMID: 39239720
Background: Reported incidence of blood transfusion reactions (TR) varies greatly. Objective: To prospectively evaluate the incidence of acute TRs in dogs receiving allogenic blood products, using consensus definitions, and to...
2.
Brooks M, Brooks J, Catalfamo J, Zhu Y, Goggs R, Babasyan S, et al.
J Vet Intern Med . 2024 Aug; 38(5):2507-2517. PMID: 39143652
Background: Immune thrombocytopenia (ITP) is a common cause of severe thrombocytopenia in dogs. The pathogenesis of nonassociative, primary ITP (pITP) appears complex, with ill-defined thrombopoietic response. Objectives: Develop an immunoassay...
3.
LeVine D, Goggs R, Kohn B, Mackin A, Kidd L, Garden O, et al.
J Vet Intern Med . 2024 May; 38(4):1982-2007. PMID: 38779941
Management of immune thrombocytopenia (ITP) in dogs and cats is evolving, but there are no evidence-based guidelines to assist clinicians with treatment decisions. Likewise, the overall goals for treatment of...
4.
LeVine D, Kidd L, Garden O, Brooks M, Goggs R, Kohn B, et al.
J Vet Intern Med . 2024 May; 38(4):1958-1981. PMID: 38752421
Immune thrombocytopenia (ITP) is the most common acquired primary hemostatic disorder in dogs. Immune thrombocytopenia less commonly affects cats but is an important cause of mortality and treatment-associated morbidity in...
5.
Chappell K, Van Vertloo L, Viall A, Scaccianoce J, LeVine D
Am J Vet Res . 2024 Jan; :1-7. PMID: 38262140
Objective: The first objective was to determine if the sample collection method (naturally voided vs digital rectal examination collection) affected fecal occult blood test (FOBT) results. The second objective was...
6.
Brooks M, Goggs R, Frye A, Armato J, Forman M, Hertl J, et al.
J Vet Intern Med . 2024 Jan; 38(2):1022-1034. PMID: 38205735
Background: Primary immune thrombocytopenia (pITP) in dogs presents a diagnostic challenge, and clinical markers of severity are lacking. Objectives: Identify clinicopathologic features that differentiate pITP from secondary ITP (sITP) and...
7.
Van Vertloo L, Portanova A, Donnini E, Hale A, LeVine D
J Vet Emerg Crit Care (San Antonio) . 2023 Feb; 33(2):242-246. PMID: 36815741
Objective: To describe the periprocedural use of a lyophilized platelet product during rhinoscopic diagnosis and treatment of sinonasal aspergillosis in a Greater Swiss Mountain Dog with a P2Y12 platelet receptor...
8.
Makielski K, Fox L, Johannes C, Rendahl A, Schulte A, Kim J, et al.
Am J Vet Res . 2022 Aug; 83(10). PMID: 35973003
Objective: To determine if dogs with neoplasia produce more coated platelets, a subpopulation of activated platelets generated by dual stimulation with thrombin and convulxin, a glycoprotein VI agonist, than healthy...
9.
Brooks M, Maruyama H, Cremer S, Goggs R, Forman M, Koch M, et al.
Vet Clin Pathol . 2022 Mar; 51(3):330-338. PMID: 35293023
Background: Canine immune thrombocytopenia (ITP) ranges from a mild to severe bleeding disorder, and platelet counts do not reliably predict clinical disease course. The detection of platelet autoantibodies may further...
10.
Allen E, Tarigo J, LeVine D, Barber J, Brainard B
J Vet Intern Med . 2021 May; 35(4):1754-1762. PMID: 33993531
Background: Vincristine might increase circulating platelet numbers but the functional capacity of these newly released platelets is unknown. Objective: To evaluate and compare the functionality of mature and immature (reticulated)...